“There are six major types of hepatitis C – genotypes 1−6. In Australia, about half of cases are caused by genotype 1, a third by genotype 3 and 5% by genotype 2. Until recently, standard treatment for chronic hepatitis C infection was with peginterferon and ribavirin . Protease inhibitors boceprevir and telaprevir were approved in 2012. Adding either of these to peginterferon and ribavirin seems to improve the response rates in people with genotype 1 disease. Sofosbuvir is another antiviral drug that can be added to combination treatment for chronic hepatitis C. “It is a direct-acting nucleotide polymerase inhibitor. You can read more about this drug in the enclosed information produced by The Australian Prescriber!
Why do we exist?
The Nursing CPD Institute (previously known as the Nurses Nurses Network) was created by Nurses, for Nurses.
We exist to help our Nursing colleagues to meet their Continuing Professional Development (CPD) annual registration standard requirement, with the Nursing and Midwifery Board of Australia.
We specialise in gathering information about Nursing and Health Care from a variety of sources to present CPD, both On-Line via our website and On-Tour on our Travel CPD events.